Clinical Trial Detail

NCT ID NCT02666950
Title WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

Adavosertib

Cytarabine

Age Groups: adult

No variant requirements are available.